1The electrical membrane characteristics and the response of the circular muscle of the guinea-pig internal anal sphincter (i.a.s.) to field stimulation were studied in vitro using intracellular microelectrodes and conventional mechanical recording techniques. 2 The i.a.s. developed its own tone (3-4 g), following initial stretch (1 g) and spontaneous spike potentials were evident. In the absence of spike potentials, tone declined and disappeared. Tone was not significantly reduced by phentolamine (I x 10-6M). The resting membrane potential, measured between spontaneous spike potentials, was -45 ± 3.0 mV (n = 224); the space constant (A) was 1 .13 ± 0.1 mm (n = 13). Spikes usually overshot by approximately 15 mV. 3 The frequency of spike potential discharge (1-3 Hz) varied with the degree of membrane depolarization, being increased in K+-rich and decreased in K+-deficient solutions or by the presence of Mn2". It was not significantly affected by Cl --withdrawal but was increased in Na'-deficient solutions with or without tetrodotoxin (TTX; I x 10-6M). 4 Field stimulation (1-20 Hz, 0.5 ms, supramaximal voltage) produced inhibitoryjunction potentials (i.j.ps) and relaxed tone; at high frequencies (50 Hz or greater), contractions were observed but excitatory junction potentials (ej.ps) were not. Ij.ps and relaxations were inhibited by apamin (1 X 10-6M), TTX (I X 10-6M) but not by atropine (1 x 10-6M), phentolamine (I x 10-6M) or hexamethonium (1 x 10-6M). 5 Ij.ps were reduced by hyperpolarization and enhanced by depolarization of the membrane by current pulses (15 s). The mean equilibrium potential for the ij.p. was -94 mV (correlation coefficient, y = 0.71, n = 5, p <0.001). Ij.ps were enhanced in K+-deficient solutions and reduced in K+-rich solutions. Together these results suggest that the ij.p. is mediated by an increased GK. The absence of [Ca2"0 or the presence of Mn2+ (2 mM) abolished the ij.p.; in contrast Na+-deficient or Cl -free solutions were ineffective in this respect. 6 Tetraethylammonium (5-50 mM) abolished the i j.p.; the accompanying relaxation was reduced by about 80%. The major aspect of the relaxation to nerve stimulation is mediated by membrane hyperpolarization.
The effects of apomorphine, catechol, clonidine, isoprenaline, (‐)‐and (±)‐noradrenaline, phenylephrine, pyrogallol and xylazine were investigated on the frequency and amplitude of miniature endplate potentials (m.e.p.ps) and, with the exception of apomorphine, catechol and pyrogallol, on the amplitude of endplate potentials (e.p.ps) in the rat phrenic nerve diaphragm preparation.
Clonidine, (‐)‐noradrenaline, phenylephrine and xylazine (each at 1.5 × 10−5M) increased m.e.p.p. frequency but not amplitude. The other drugs were ineffective, except isoprenaline (1.5 × 10−5 M) which enhanced m.e.p.p. amplitude but not frequency.
The increase in m.e.p.p. frequency was inhibited by phentolamine, prazosin and yohimbine (each 1.5 × 10−9M). Prazosin and yohimbine alone each reduced m.e.p.p. frequency but failed to abolish m.e.p.ps even at high concentrations (10−3M).
Clonidine, (‐)‐noradrenaline, phenylephrine and xylazine (each 3 × 10−6M) enhanced e.p.p. amplitude; this enhancement was blocked by prazosin and by yohimbine (each 3 × 10−6M).
In preparations fatigued by prolonged continuous nerve stimulation (5 Hz, 0.05 ms for 30 min), (‐)‐noradrenaline (3.3 × 10−4M) restored m.e.p.p. frequency.
The results indicate that adrenoceptors on somatic nerve terminals interact with both α1‐ and α2‐agonists and antagonists and show different characteristics from those at autonomic neuroeffector junctions.
The α‐adrenoceptors on somatic nerve terminals may have an ancilliary physiological role in influencing but not controlling transmitter release.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.